The touting of Crossover tranches as a hedge for CLO investments has prompted debate in the market, with some seeing the instrument as adding a useful tool while others remain sceptical.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Dan Alderson